Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Phosphorylated signal transducer and activator of transcription 1 is a potential predictor of interferon response in patients with advanced renal cell carcinoma.

Li W, Wei Q, Liang J.

Mol Med Rep. 2014 May;9(5):1929-34. doi: 10.3892/mmr.2014.2046. Epub 2014 Mar 13.

PMID:
24626739
2.

Defective Jak-Stat activation in renal cell carcinoma is associated with interferon-alpha resistance.

Shang D, Liu Y, Ito N, Kamoto T, Ogawa O.

Cancer Sci. 2007 Aug;98(8):1259-64. Epub 2007 Jun 15.

3.

Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.

Lesinski GB, Trefry J, Brasdovich M, Kondadasula SV, Sackey K, Zimmerer JM, Chaudhury AR, Yu L, Zhang X, Crespin TR, Walker MJ, Carson WE 3rd.

Clin Cancer Res. 2007 Sep 1;13(17):5010-9.

4.

Suppression of interferon-α signaling by hepatitis E virus.

Dong C, Zafrullah M, Mixson-Hayden T, Dai X, Liang J, Meng J, Kamili S.

Hepatology. 2012 May;55(5):1324-32. doi: 10.1002/hep.25530. Epub 2012 Apr 4.

PMID:
22183878
5.

Phosphorylated signal transducer and activator of transcription-1 immunohistochemical expression is associated with improved survival in patients with oral squamous cell carcinoma.

Pappa E, Nikitakis N, Vlachodimitropoulos D, Avgoustidis D, Oktseloglou V, Papadogeorgakis N.

J Oral Maxillofac Surg. 2014 Jan;72(1):211-21. doi: 10.1016/j.joms.2013.06.198. Epub 2013 Aug 29.

PMID:
23992782
6.

Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma.

Furuya N, Kamai T, Shirataki H, Yanai Y, Fukuda T, Mizuno T, Nakamura F, Kambara T, Nakanishi K, Abe H, Yoshida K.

Cancer Immunol Immunother. 2011 Jun;60(6):793-808. doi: 10.1007/s00262-011-0989-3. Epub 2011 Feb 25.

7.

Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma.

Betsunoh H, Fukuda T, Anzai N, Nishihara D, Mizuno T, Yuki H, Masuda A, Yamaguchi Y, Abe H, Yashi M, Fukabori Y, Yoshida K, Kamai T.

BMC Cancer. 2013 Oct 30;13:509. doi: 10.1186/1471-2407-13-509.

8.

Expression of interferon-γ, interferon-α and related genes in individuals with Down syndrome and periodontitis.

Tanaka MH, Giro EM, Cavalcante LB, Pires JR, Apponi LH, Valentini SR, Spolidório DM, Capela MV, Rossa C Jr, Scarel-Caminaga RM.

Cytokine. 2012 Dec;60(3):875-81. doi: 10.1016/j.cyto.2012.08.020. Epub 2012 Sep 18.

9.

STAT1 expression and activation is increased in lesional psoriatic skin.

Hald A, Andrés RM, Salskov-Iversen ML, Kjellerup RB, Iversen L, Johansen C.

Br J Dermatol. 2013 Feb;168(2):302-10. doi: 10.1111/bjd.12049.

PMID:
23013371
10.

Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis.

Kamai T, Yanai Y, Arai K, Abe H, Yamanishi T, Kurimoto M, Yoshida K.

BMC Cancer. 2007 Aug 15;7:159.

11.

Illicium verum extract suppresses IFN-γ-induced ICAM-1 expression via blockade of JAK/STAT pathway in HaCaT human keratinocytes.

Sung YY, Kim HK.

J Ethnopharmacol. 2013 Oct 7;149(3):626-32. doi: 10.1016/j.jep.2013.07.013. Epub 2013 Jul 18.

PMID:
23872327
12.

Cytokine expression and signaling in drug-induced cellular senescence.

Novakova Z, Hubackova S, Kosar M, Janderova-Rossmeislova L, Dobrovolna J, Vasicova P, Vancurova M, Horejsi Z, Hozak P, Bartek J, Hodny Z.

Oncogene. 2010 Jan 14;29(2):273-84. doi: 10.1038/onc.2009.318. Epub 2009 Oct 5.

PMID:
19802007
13.

Radiosensitization by inhibiting STAT1 in renal cell carcinoma.

Hui Z, Tretiakova M, Zhang Z, Li Y, Wang X, Zhu JX, Gao Y, Mai W, Furge K, Qian CN, Amato R, Butler EB, Teh BT, Teh BS.

Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):288-95. doi: 10.1016/j.ijrobp.2008.08.043.

PMID:
19100922
14.

STAT1 modification improves therapeutic effects of interferons on lung cancer cells.

Chen J, Zhao J, Chen L, Dong N, Ying Z, Cai Z, Ji D, Zhang Y, Dong L, Li Y, Jiang L, Holtzman MJ, Chen C.

J Transl Med. 2015 Sep 8;13:293. doi: 10.1186/s12967-015-0656-0.

16.

Inhibition of Jak1-dependent signal transduction in airway epithelial cells infected with adenovirus.

Shi L, Ramaswamy M, Manzel LJ, Look DC.

Am J Respir Cell Mol Biol. 2007 Dec;37(6):720-8. Epub 2007 Jul 19.

17.

In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer.

Hathorn RW, Tso CL, Kaboo R, Pang S, Figlin R, Sawyers C, deKernion JB, Belldegrun A.

Cancer. 1994 Oct 1;74(7):1904-11.

PMID:
7521786
18.

Is Stat3 and/or p53 mRNA expression a prognostic marker for renal cell carcinoma?

Masuda A, Kamai T, Abe H, Arai K, Yoshida K.

Biomed Res. 2009 Jun;30(3):171-6.

19.

Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.

Ma X, Fan Y, Gao Y, Zhang Y, Huang Q, Ai Q, Ni D, Chen W, Zhang P, Song E, Wang B, Shi T, Zheng T, Zhang X.

Urol Oncol. 2014 Jan;32(1):46.e9-17. doi: 10.1016/j.urolonc.2013.06.011. Epub 2013 Oct 4.

PMID:
24094887
20.

Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection.

Miyagi T, Takehara T, Nishio K, Shimizu S, Kohga K, Li W, Tatsumi T, Hiramatsu N, Kanto T, Hayashi N.

J Hepatol. 2010 Sep;53(3):424-30. doi: 10.1016/j.jhep.2010.03.018. Epub 2010 May 25.

PMID:
20554341

Supplemental Content

Support Center